Blue Note’s failure to clear the FDA hurdle offers a rare window into the regulatory challenges faced by digital therapeutics ...

The Senate report extensively cites STAT’s investigation of the use of algorithms and artificial intelligence within Medicare ...

Telehealth sites prescribing GLP-1s online can get off the ground in a matter of days by “renting” the services of these ...

Unfortunately, many of our elected leaders today undervalue the role of patents to progress the science of drug discovery and ...

Pitts, a former FDA associate commissioner, is president of the Center for Medicine in the Public Interest and a visiting ...

FDA leaders said the agency was willing to consider broader endpoints in clinical trials of smoking cessation products ...

Republicans will need to rework Biden’s drug pricing law and let the expanded ACA subsidies end, should Trump take office.

Barney Graham, a former NIH vaccine developer, said U.S. agencies aren't coordinating the response to the bird flu outbreak ...

"We really have to stop treating women as if they were small men," a surgeon says in response to a study of women's higher ...

Onward Medical is betting big on neurostimulation as a tool to improve the quality of life for people with paralysis, said ...

The U.K. will study whether Lilly's weight loss drug can get people back to work and help tackle long-term sickness ...

The FDA yesterday the approval of Novocure’s Optune device to include the treatment of metastatic non-small cell lung cancer.